More recently, Koutny et al., using serum ALT levels as a proxy for MASLD, examined the longitudinal data from 32,325 children (age 2-17 years) with T1D in the Diabetes-Patienten-Verlaufsdokumentation study (39). The gene discussed is GPT; the disease is type 1 diabetes mellitus.